Ishara Investments LP

Ishara Investments LP reported 41 holdings worth US$136M as of Jun 30, 2026 (Form 13F)

As of Jun 30, 2026 · Filed Aug 14, 2026

Ishara Investments LP reported 41 holdings worth US$136M as of Jun 30, 2026. Largest: Acadia Pharmaceuticals Inc., Xeris Biopharma Holdings, Inc. and Biomarin Pharmaceutical Inc. Filed Aug 14, 2026 (Form 13F).

Holdings
41
Value as reported
US$136M

The filing in full

CompanySharesValue as reported% of portfolio
Acadia Pharmaceuticals Inc.410KUS$10.4M7.6%
Xeris Biopharma Holdings, Inc.1.23MUS$9.74M7.2%
Biomarin Pharmaceutical Inc.144KUS$8.21M6.0%
Praxis Precision Medicines, Inc.22,550US$7.55M5.5%
Ultragenyx Pharmaceutical Inc.205KUS$6.84M5.0%
Agios Pharmaceuticals, Inc.164KUS$6.09M4.5%
Insmed Incorporated51,250US$5.46M4.0%
Crinetics Pharmaceuticals, Inc.144KUS$5.37M3.9%
Zentalis Pharmaceuticals, Inc.1.02MUS$4.97M3.7%
Vaxcyte, Inc.82,000US$4.77M3.5%
Annexon, Inc.820KUS$4.68M3.4%
Travere Therapeutics, Inc.82,000US$4.66M3.4%
Tonix Pharmaceuticals Holding Corp.338KUS$4.32M3.2%
Bridgebio Pharma, Inc.57,400US$4.28M3.1%
Axsome Therapeutics, Inc.16,400US$4.01M2.9%
Contineum Therapeutics, Inc.205KUS$3.36M2.5%
Lexicon Pharmaceuticals, Inc.1.27MUS$3.05M2.2%
Kura Oncology, Inc.277KUS$3.04M2.2%
Dbv Technologies Sa185KUS$3.03M2.2%
Genmab A/s103KUS$2.82M2.1%
Cytokinetics, Incorporated32,800US$2.79M2.1%
Mineralys Therapeutics, Inc.103KUS$2.77M2.0%
Nuvation Bio Inc.369KUS$2.1M1.5%
Nektar Therapeutics26,650US$1.86M1.4%
Scholar Rock Holding Corporation30,750US$1.69M1.2%
Enliven Therapeutics, Inc.32,800US$1.66M1.2%
Alnylam Pharmaceuticals, Inc.5,125US$1.54M1.1%
Beam Therapeutics Inc.41,000US$1.41M1.0%
Sionna Therapeutics, Inc.123KUS$1.35M0.99%
Oric Pharmaceuticals, Inc.123KUS$1.33M0.98%
Vertex Pharmaceuticals Incorporated2,460US$1.22M0.90%
Ars Pharmaceuticals, Inc.143KUS$1.15M0.84%
Monopar Therapeutics Inc.12,300US$1.14M0.84%
Erasca, Inc.41,000US$751K0.55%
Vera Therapeutics, Inc.10,250US$440K0.32%
Gossamer Bio, Inc.820KUS$135K0.10%
Edgewise Therapeutics, Inc.0US$00.00%
Ideaya Biosciences, Inc.0US$00.00%
Kalvista Pharmaceuticals, Inc.0US$00.00%
Ligand Pharmaceuticals Incorporated0US$00.00%
Ptc Therapeutics, Inc.0US$00.00%
Verastem, Inc.0US$00.00%
Ardelyx, Inc.0US$00.00%
Arrowhead Pharmaceuticals, Inc.0US$00.00%
Catalyst Pharmaceuticals, Inc.0US$00.00%

Source

View original at SEC

Related